A new study of hundreds of patient records has added to evidence that it’s likely best to use as little corticosteroid medicine as possible when treating people who have lupus, a common heart complication of the autoimmune disorder.
Systemic lupus erythematosus, more commonly known as lupus, has a variety of symptoms and room for improvement when it comes to treatment.Cutaneous lupus erythematosus is a common manifestation of systemic lupus erythematosus.The condition is characterized by rashes on various parts of the body including the face and scalp, hair loss and scarring of the skin.
An increase in nightmares and hallucinations could signal the onset of autoimmune diseases such as lupus, according to a new study.
Researchers from Johns Hopkins Medicine say they have uncovered insights as to why lupus symptoms and severity present differently in individuals with the autoimmune condition, which affects up to 1.5 million Americans.
Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.
Below are some of the latest research and features on this growing population of older adults in the Seniors channel on Newswise.
NJ-based Atlantic Health System is the first in the U.S. to enroll a patient in a study to examine the effectiveness of using Chimeric Antigen Receptor (CAR- T) cells in the treatment of the autoimmune disease lupus.
The latest research and expertise on the flue can be found in the Influenza channel on Newswise.
New biomarkers with improved diagnostic performance for early detection of lupus nephritis have been discovered in the University of Houston lab of Chandra Mohan, a pioneer in lupus research.
Find the latest research and features on emergency medicine in the Emergency Medicine channel on Newswise.
In some diseases, the underlying processes can start years before a diagnosis is made. A new study finds that people who later develop multiple sclerosis (MS) are more likely to have conditions like depression, constipation and urinary tract infections five years before their MS diagnosis than people who do not develop MS.
Despite being one of the highest lupus populations, Black adults are often left behind. A rheumatologist discusses ways to improve the issue
Obinutuzumab preserved kidney function, prevented flares in lupus nephritis trial.
Researchers at Stanford University School of Medicine, Yale University School of Medicine, and the Hospital for Special Surgery Research Institute have uncovered new details about how the immune system prevents the production of antibodies that can recognize and damage the body’s own, healthy tissues. The study, to be published September 29 in the Journal of Experimental Medicine (JEM), also reveals how this process is impaired in autoimmune disorders such as systemic sclerosis and systemic lupus erythematosus and suggests potential new strategies to treat these diseases.
Below are some of the latest headlines in the Women's Health channel on Newswise.
Researcher will discuss the study which involved a sleeping aid known as suvorexant that is already approved by the Food and Drug Administration (FDA) for insomnia, hints at the potential of sleep medications to slow or stop the progression of Alzheimer’s disease.
From septic shock to sticker shock. Keep up with this ever-growing, changing sector. Below are some of the latest stories on healthcare on Newswise.
Nicknamed the “invisible disease”, lupus is an autoimmune disorder that disproportionately affects women and even more specifically, Black women. It occurs when the immune system begins a pattern of attacking the body’s organs when immune cells are inappropriately activated in the body. It’s difficult to diagnose, and when it is, it’s accompanied by major lifestyle changes to help keep the condition under control.
Below are some of the latest articles that have been added to the Surgery and the Transplantation channels on Newswise, a free source for journalists.
A group of researchers from the Graduate School of Medicine at Nagoya University in Japan have discovered the impact of microRNA (miRNA) on inflammation in lupus in mice.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right
